Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
C18 NEGATIVE ION MODE | FFA(20:0) | 1287059.379 | Peak area normalized | male | Diabetic | no neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1426226.892 | Peak area normalized | male | Normoglycemic | Neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1435088.336 | Peak area normalized | female | Diabetic | no neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1524562.498 | Peak area normalized | female | Pre-diabetic | Neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1582305.064 | Peak area normalized | male | Pre-diabetic | no neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1634510.196 | Peak area normalized | male | Diabetic | Neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1643206.613 | Peak area normalized | female | Pre-diabetic | no neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1643600.785 | Peak area normalized | female | Diabetic | no neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1668335.55 | Peak area normalized | female | Diabetic | Neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1695472.604 | Peak area normalized | male | Pre-diabetic | Neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1750936.711 | Peak area normalized | female | Pre-diabetic | Neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1753314.142 | Peak area normalized | female | Pre-diabetic | no neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1771683.183 | Peak area normalized | male | Diabetic | Neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1800531.409 | Peak area normalized | male | Diabetic | Neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1801689.336 | Peak area normalized | female | Pre-diabetic | Neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1857516.812 | Peak area normalized | female | Pre-diabetic | no neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1862722.957 | Peak area normalized | male | Normoglycemic | no neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1873669.61 | Peak area normalized | male | Diabetic | no neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1894379.103 | Peak area normalized | female | Diabetic | Neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1973226.129 | Peak area normalized | male | Pre-diabetic | no neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 2084595.599 | Peak area normalized | female | Pre-diabetic | Neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 2153205.612 | Peak area normalized | male | Normoglycemic | no neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 2171818.443 | Peak area normalized | male | Pre-diabetic | Neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 2208571.431 | Peak area normalized | male | Diabetic | no neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 2254875.219 | Peak area normalized | male | Normoglycemic | Neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 2640374.835 | Peak area normalized | female | Pre-diabetic | no neuropathy |